Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

0
Player Avatar EnigmaDude (97.99) Submitted: 8/26/2011 12:23:03 PM : Outperform Start Price: $17.01 VIVO Score: +0.97

Stock near 52-wk low and just raised guidance for 2012.

Featured Broker Partners


Advertisement